company

TELEMARK NEVROSENTER AS

3734 SKIEN

Return on Equity
827,75 %
Current Ratio
0,93
Debt-to-Equity Ratio
4,67
Key figures (NOK)2022
Revenue6 535 000
Net Income1 879 000
Total Assets3 909 000
Total Equity227 000
Income (NOK)2022
Revenue6 535 000
Expenditure4 039 000
Operating Profit2 497 000
Financial Income0
Financial Costs87 000
Financial Balance−87 000
Earnings Before Tax2 410 000
Tax531 000
Net Income1 879 000
Balance (NOK)2022
Total Fixed Assets1 460 000
Total Current Assets2 449 000
Total Assets3 909 000
Total Retained Equity197 000
Total Equity227 000
Total Long-Term Debt1 060 000
Total Current Debt2 622 000
Total Equity and Debt3 909 000
Cash flow (NOK)2022
Sales Income6 535 000
Other Income0
Revenue6 535 000
Cost of Goods Sold0
Salary Costs2 394 000
Depreciation357 000
Impairment0
Expenditure4 039 000
Operating Profit2 497 000
Financial Income0
Financial Costs87 000
Financial Balance−87 000
Dividends1 700 000
Net Income1 879 000
Balance details (NOK)2022
Goodwill1 175 000
Total Intangible Assets1 175 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures275 000
Total Tangible Assets275 000
Total Fiancial Fixed Assets10 000
Total Fixed Assets1 460 000
Stock0
Total Investments0
Cash, Bank2 266 000
Total Current Assets2 449 000
Total Assets3 909 000
Total Equity227 000
Short-Term Group Debt0
Total Long-Term Debt1 060 000
Creditors57 000
Unpaid Taxes172 000
Dividends1 700 000
Other Current Debt218 000
Total Current Debt2 622 000
Total Equity and Debt3 909 000
Financial indicators2022
Return on Equity827,75 %
Debt-to-Equity Ratio4,67
Operating Profit Margin38,21 %
Current Ratio0,93
Quick Ratio0,93
Equity Ratio0,06
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English